USL-311 Uses, Dosage, Side Effects and more
USL-311 is under investigation in clinical trial NCT02765165 (Phase 1/2 Study of USL311 Alone and in Combination With Lomustine in Subjects With Advanced Solid Tumors and Relapsed/Recurrent Glioblastoma Multiforme (GBM)).
| Trade Name | USL-311 |
| Generic | USL-311 |
| Type | |
| Formula | C24H34N6O |
| Weight | Average: 422.577 Monoisotopic: 422.279409739 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
